Michael Joseph Golembiewski's Net Worth

-$60.8 Thousand

Estimate Recalculated Mar 1, 2024 05:41PM EST

Who is Michael Joseph Golembiewski?

Michael Joseph Golembiewski does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include SEELOS THERAPEUTICS, INC., and PERNIX THERAPEUTICS HOLDINGS, INC..

SEC CIK

Michael Joseph Golembiewski's CIK is 0001639479

Past Insider Trading and Trends

2023 was Michael Joseph Golembiewski's most active year for acquiring shares with 5 total transactions. Michael Joseph Golembiewski's most active month to acquire stocks was the month of January. 2023 saw Michael Joseph Golembiewski paying a total of $116,347.50 for 873,731 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

SEELOS THERAPEUTICS, INC. (SEEL) Snapshot price: $0.7728

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.48%
417
$1.10
$457.45
86.87K
Feb 29
Form 4
—
0
—
—
0
Jan 12
Form 4
+2,405.80%
83K
$1.21
$100,222.50
86.45K
Nov 30
Form 4
+13.74%
12.5K
$0.62
$7,725.00
103.49K
Aug 31
Form 4
—
0
—
—
0
Mar 30
Form 4
+15.93%
12.5K
$0.67
$8,400.00
90.99K
Feb 28
Form 4
+18.94%
12.5K
$0.90
$11,262.50
78.49K
Feb 28
Form 4
—
0
—
—
0
Jan 10
Form 3
—
0
—
—
0
No matching records found

PERNIX THERAPEUTICS HOLDINGS, INC. No price found

VP Finance, Controller, CAO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
3.3K
—
—
3.3K
Aug 8
Form 4
—
0
—
—
0
Feb 25
Form 4
—
0
—
—
0
Apr 6
Form 3
—
0
—
—
0
No matching records found